New discovery suggests a novel strategy against harmful inflammation
New breakthrough reveals how prostate cancer may begin
22 September 2022Could monoclonal antibodies replace opioids for chronic pain?
22 September 2022New discovery suggests a novel strategy against harmful inflammation
A team led by Scripps Research scientists has uncovered key details of an immune cell process that frequently underlies excessive inflammation in the body. The findings could lead to new ways of preventing and/or treating inflammation-related conditions such as sepsis, arthritis, and coronary artery disease.
